Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sonoscan is a global leader in Acoustic Micro Imaging (AMI) technology, specializing in the development of non-destructive inspection systems for the microelectronics and medical device industries. The company's flagship C-SAM (C-mode Scanning Acoustic Microscope) technology allows for the detection of internal defects such as delaminations, cracks, and voids without damaging the sample. In healthcare and life sciences, Sonoscan's systems are used to ensure the reliability of implantable devices and to perform high-frequency ultrasonic imaging of biological tissues. Acquired by Nordson Corporation in 2018, the company continues to provide advanced laboratory services and automated inspection equipment to a diverse range of high-tech industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sonoscan.